|Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research …|
K Visser, W Katchamart, E Loza, JA Martinez-Lopez, C Salliot, J Trudeau, ...
Annals of the rheumatic diseases 68 (7), 1086-1093, 2009
|Interleukin-6 as a key player in systemic inflammation and joint destruction|
JE Fonseca, MJ Santos, H Canhao, E Choy
Autoimmunity reviews 8 (7), 538-542, 2009
|Osteoblasts and bone formation.|
J Caetano-Lopes, H Canhao, J Eurico Fonseca
Acta reumatológica portuguesa 32 (2), 2007
|Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis|
P Stolt, A Yahya, C Bengtsson, H Källberg, J Rönnelid, I Lundberg, ...
Annals of the rheumatic diseases 69 (6), 1072-1076, 2010
|Osteoimmunology—the hidden immune regulation of bone|
J Caetano-Lopes, H Canhao, JE Fonseca
Autoimmunity reviews 8 (3), 250-255, 2009
|Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis|
J Cui, EA Stahl, S Saevarsdottir, C Miceli, D Diogo, G Trynka, T Raj, ...
PLoS genetics 9 (3), e1003394, 2013
|Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis|
R Cascão, RA Moura, I Perpétuo, H Canhão, E Vieira-Sousa, AF Mourão, ...
Arthritis research & therapy 12 (5), R196, 2010
|Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from …|
JC Branco, AM Rodrigues, N Gouveia, M Eusébio, S Ramiro, ...
RMD open 2 (1), e000166, 2016
|Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis|
H Canhão, AM Rodrigues, AF Mourão, F Martins, MJ Santos, ...
Rheumatology 51 (11), 2020-2026, 2012
|Classification of systemic lupus erythematosus: Systemic Lupus International Collaborating Clinics versus American College of Rheumatology criteria. A comparative study of 2 …|
L Inês, C Silva, M Galindo, FJ López‐Longo, G Terroso, VC Romão, ...
Arthritis care & research 67 (8), 1180-1185, 2015
|Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research …|
P Machado, I Castrejon, W Katchamart, R Koevoets, B Kuriya, M Schoels, ...
Annals of the rheumatic diseases 70 (1), 15-24, 2011
|Reuma. pt-the rheumatic diseases portuguese register|
H Canhão, A Faustino, F Martins, JE Fonseca, P Nero, JC Branco
Acta reumatologica portuguesa 36 (1), 45-56, 2011
|Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival|
RA Moura, R Cascão, I Perpétuo, H Canhão, E Vieira-Sousa, AF Mourão, ...
Rheumatology 50 (2), 278-282, 2010
|Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience|
JE Fonseca, H Canhao, C Silva, C Miguel, MJ Mediavilla, A Teixeira, ...
Acta reumatologica portuguesa 31 (3), 247-253, 2006
|Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?|
VC Romao, A Lima, M Bernardes, H Canhao, JE Fonseca
Immunologic research 60 (2-3), 289-310, 2014
|Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?|
VC Romão, H Canhão, JE Fonseca
BMC medicine 11 (1), 17, 2013
|Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers|
LK Mercer, J Askling, P Raaschou, WG Dixon, L Dreyer, ML Hetland, ...
Annals of the rheumatic diseases 76 (2), 386-391, 2017
|Bilateral MR imaging of the hand and wrist in early and very early inflammatory arthritis: tenosynovitis is associated with progression to rheumatoid arthritis|
M Navalho, C Resende, AM Rodrigues, F Ramos, A Gaspar, ...
Radiology 264 (3), 823-833, 2012
|Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter|
JE Fonseca, J Cavaleiro, J Teles, E Sousa, VL Andreozzi, M Antunes, ...
Arthritis research & therapy 9 (2), R37, 2007
|TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits|
D Diogo, L Bastarache, KP Liao, RR Graham, RS Fulton, JD Greenberg, ...
PloS one 10 (4), e0122271, 2015